Cardiovascular Disease, Atherosclerosis

2041 Words5 Pages

One source of great mortality and morbidity in Europe and North America is the cardiovascular disease, Atherosclerosis. It is recognized as a chronic inflammatory disease of the intermediate and large arteries characterized by the thickening of the arterial wall and is the primary cause of coronary and cerebrovascular heart disease (Wilson, 2005). It accounts for 4.35 million deaths in Europe and 35% death in the UK each year. Mortality rate are generally higher in men than pre-menopausal woman. Past the menopause, a woman’s risk is similar to a man’s (George and Johnston, 2010). Clinical trials have confirmed that lipid accumulation, endothelial dysfunction, cell proliferation, inflammation matrix alteration and foam cell formation are characteristic features of the earliest pathogenesis of atherosclerotic disease, and that therapies targeted towards the treatment of those conditions are beneficial (Varghese et al 2005). This essay will summarise the development and factors predispose to atherogenesis, and discuss how the comprehension of cell and molecular based mechanism has led to novel therapies for atherosclerosis.

Atherosclerosis is a disease in which plaque builds up inside the arteries. Arteries are blood vessels that carry oxygen-rich blood to the heart and other parts of your body. It develops by the accumulation of excess Low Density Lipoprotein (LDL) in the arterial wall causing damage to the vascular endothelium which increases expression of adhesion molecules that latch onto monocytes and T cells and decreases the ability of the endothelial cells to release Nitric oxide (NO). Monocytes and LDL accumulates at the site of injury then penetrates the intima where monocytes differenciate to become macrophages and the ...

... middle of paper ...

... Francis Group: London Edited by Joseph Loscalzo

Serruys P. W, Gershlick A. H (2005)’ Handbook of drug-eluting stents’ Taylor and francis group: Oxonia

Stancu C and Sima A (2001) Statins: mechanism of action and effects Published in J.Cell.Mol.Med. Vol 5, No 4, 2001 pp. 378-387

Varghese Z, Fernando R, Moorhead J. F, Powis S. H, and Ruan X. Z (2005) ‘Effects of sirolimus on mesangial cell cholesterol homeostasis: a novel mechanism for its action against lipid-mediated injury in renal allografts’ Published in Translational Physiology :London,

Vaughan C. J, Gotto A. M Jr., and Basson C. T, (2000) ‘The evolving role of statins in the management of atherosclerosis’ Published in Journal of the American college of cardiology

35:1-10

Wilson P. W. F. (2005) Molecular Mechanisms of Atherosclerosis Taylor and Francis Group: London Edited by Joseph Loscalzo

Open Document